Global dynamics and strategic transition: a bibliometric mapping of the paradigm shift in metal–organic frameworks for oncology (1981–2025)
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (79)
Show source-provided references
1. Guo Y, Wu S, Wen Z (2022) Application progress of metal-organic frameworks in tumors therapy. Cancer Research on Prevention and Treatment 49:472–477. https://doi.org/10.3971/j.issn.1000-8578.2022.21.115810.3971/j.issn.1000-8578.2022.21.1158 ↗
2. Luo Z, Sheng Y, Jiang C, Pan Y, Wang X, Nezamzadeh-Ejhieh A, Ouyang J, Lu C, Liu J (2023) Recent advances and prospects of metal-organic frameworks in cancer therapies. Dalton Trans 52:17601–17622. https://doi.org/10.1039/d3dt02543h10.1039/d3dt02543h ↗
3. Patil JH, Patel JK, Shah UA, Patil PO, Chaudhari AS, Goswami HH (2024) A comprehensive review on metal-organic frameworks for stimuli-responsive-based drug delivery: recent advances and future trends. Nano Biomed Eng 16:285–308. https://doi.org/10.26599/NBE.2024.929007810.26599/NBE.2024.9290078 ↗
4. Tarin M, Oryani MA, Javid H, Karimi-Shahri M (2025) Exosomal PD-L1 in non-small cell lung cancer: implications for immune evasion and resistance to immunotherapy. Int Immunopharmacol 155:114519. https://doi.org/10.1016/j.intimp.2025.11451910.1016/j.intimp.2025.114519 ↗
5. Feng Y, Wu W, Li M (2022) Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism. Front Pharmacol. https://doi.org/10.3389/fphar.2022.102578010.3389/fphar.2022.1025780 ↗
6. Figueira F, Tomé JPC, Paz FAA (2022) Porphyrin nanometal-organic frameworks as cancer theranostic agents. Molecules. https://doi.org/10.3390/molecules2710311110.3390/molecules27103111 ↗
7. Xu Q, Li C, Chen Y, Zhang Y, Lu B (2021) Metal-organic framework-based intelligent drug delivery systems for cancer theranostic: a review. Front Mater Sci 15:374–390. https://doi.org/10.1007/s11706-021-0568-210.1007/s11706-021-0568-2 ↗
8. Akbari Oryani M, Tarin M, Rahnama Araghi L, Rastin F, Javid H, Hashemzadeh A, Karimi-Shahri M (2025) Synergistic cancer treatment using porphyrin-based metal-organic frameworks for photodynamic and photothermal therapy. J Drug Target 33:473–491. https://doi.org/10.1080/1061186x.2024.243355110.1080/1061186x.2024.2433551 ↗
9. Attarian F, Hatamian G, Nosrati S, Akbari Oryani M, Javid H, Hashemzadeh A, Tarin M (2025) Role of liposomes in chemoimmunotherapy of breast cancer. J Drug Target 33:887–91510.1080/1061186X.2025.2467139 ↗
10. Khorramdel M, Ghadikolaii FP, Hashemy SI, Javid H, Tabrizi MH (2024) Nanoformulated meloxicam and rifampin: inhibiting quorum sensing and biofilm formation in Pseudomonas aeruginosa. Nanomedicine (Lond) 19:615–632. https://doi.org/10.2217/nnm-2023-026810.2217/nnm-2023-0268 ↗
11. Li S, Tan L, Meng X (2020) Nanoscale metal-organic frameworks: synthesis, biocompatibility, imaging applications, and thermal and dynamic therapy of tumors. Adv Funct Mater. https://doi.org/10.1002/adfm.20190892410.1002/adfm.201908924 ↗
12. Sun W, Li S, Tang G, Luo Y, Ma S, Sun S, Ren J, Gong Y, Xie C (2019) Recent progress of nanoscale metal-organic frameworks in cancer theranostics and the challenges of their clinical application. Int J Nanomedicine 14:10195–10207. https://doi.org/10.2147/IJN.S23052410.2147/IJN.S230524 ↗
13. Tarin M, Oryani MA, Javid H, Hashemzadeh A, Karimi-Shahri M (2025) Advancements in chitosan-based nanocomposites with ZIF-8 nanoparticles: multifunctional platforms for wound healing applications. Carbohydr Polym 362:123656. https://doi.org/10.1016/j.carbpol.2025.12365610.1016/j.carbpol.2025.123656 ↗
14. Kitagawa S, Matsuda R (2007) Chemistry of coordination space of porous coordination polymers. Coord Chem Rev 251:2490–2509. https://doi.org/10.1016/j.ccr.2007.07.00910.1016/j.ccr.2007.07.009 ↗
15. Furukawa H, Cordova KE, O’Keeffe M, Yaghi OM (2013) The chemistry and applications of metal-organic frameworks. Science 341:1230444. https://doi.org/10.1126/science.123044410.1126/science.1230444 ↗
16. Zhao J, Zhang Y, Luo Y, Zheng W, Xu X, Luo F (2024) Amorphous metal–organic frameworks: pioneering frontiers in cancer diagnostics and therapeutics. Chem Eng J. https://doi.org/10.1016/j.cej.2024.15229510.1016/j.cej.2024.152295 ↗
17. Jiang XR, Mi J, Wang Y, Yin M, Tong Y, Zhu Y (2025) Application of metal-organic frameworks nanoparticles in the diagnosis and treatment of breast cancer. Int J Nanomedicine 20:10127–10149. https://doi.org/10.2147/IJN.S53442210.2147/IJN.S534422 ↗
18. Mehata AK, Viswanadh MK, Muthu MS (2023) Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation. Nanomedicine 18:695–703. https://doi.org/10.2217/nnm-2022-027810.2217/nnm-2022-0278 ↗
19. Osterrieth JWM, Fairen-Jimenez D (2021) Metal–organic framework composites for theragnostics and drug delivery applications. Biotechnol J. https://doi.org/10.1002/biot.20200000510.1002/biot.202000005 ↗
20. Shi C, Chen G, Ye M, Xia Z, Ye Y, Kushwaha A, Wang J, Kumar A, Pan Y (2025) Advances in AI-driven applications of metal-organic frameworks for the diagnosis and treatment of pancreatic cancer. Dyes Pigments. https://doi.org/10.1016/j.dyepig.2025.11295710.1016/j.dyepig.2025.112957 ↗
21. Yu S, Xu K, Wang Z, Zhang Z, Zhang Z (2023) Bibliometric and visualized analysis of metal-organic frameworks in biomedical application. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2023.119065410.3389/fbioe.2023.1190654 ↗
22. Cheng K, Guo Q, Shen Z, Yang W, Wang Y, Sun Z, Wu H (2022) Bibliometric analysis of global research on cancer photodynamic therapy: focus on nano-related research. Front Pharmacol. https://doi.org/10.3389/fphar.2022.92721910.3389/fphar.2022.927219 ↗
23. Wu H, Cheng K, Sun Z, Lu Y, Guo Q, Li C (2024) Trends of mapping knowledge structure and themes of cancer sonodynamic therapy: a text-mining study. Quant Imaging Med Surg 14:8734–8757. https://doi.org/10.21037/qims-24-12810.21037/qims-24-128 ↗
24. Wu Z, Cheng K, Shen Z, Lu Y, Wang H, Wang G, Wang Y, Yang W, Sun Z, Guo Q et al (2023) Mapping knowledge landscapes and emerging trends of sonodynamic therapy: a bibliometric and visualized study. Front Pharmacol. https://doi.org/10.3389/fphar.2022.104821110.3389/fphar.2022.1048211 ↗
25. Niu H, Du H, Ji Z, Li X, Xiao W, He A, Yu P, Liu G (2025) Global trends and characteristics of metal–organic frameworks in cancer research: a machine-learning-based bibliometric analysis. Discover Oncol. https://doi.org/10.1007/s12672-025-02716-810.1007/s12672-025-02716-8 ↗
26. Pattnaik AK, Priyadarshini N, Priyadarshini P, Behera GC, Parida K (2024) Recent advancements in metal organic framework-modified multifunctional materials for photodynamic therapy. Mater Adv 5:6030–6051. https://doi.org/10.1039/d4ma00376d10.1039/d4ma00376d ↗
27. Cai M, Yang Y, Kong J, Zhang Y, Li S, Zhang H, Xv X, Ni J, Yin X (2025) Nanoscale metal-organic frameworks as a versatile platform for synergistic combination tumor therapy. J Nanobiotechnology 23:601. https://doi.org/10.1186/s12951-025-03625-210.1186/s12951-025-03625-2 ↗
28. Korchef A, Souid I, Ben Fraj Trabelsi F (2023) Chemistry journals and research trends in Arab countries: a bibliometric analysis. Arab J Chem 16:105097. https://doi.org/10.1016/j.arabjc.2023.10509710.1016/j.arabjc.2023.105097 ↗
29. Burnham JF (2006) Scopus database: a review. Biomed Dig Libr 3:1–810.1186/1742-5581-3-1 ↗
30. Aria M, Cuccurullo C (2017) Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr 11:959–97510.1016/j.joi.2017.08.007 ↗
31. Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM (2021) How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res 133:285–296. https://doi.org/10.1016/j.jbusres.2021.04.07010.1016/j.jbusres.2021.04.070 ↗
32. Van Eck N, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84:523–53810.1007/s11192-009-0146-3 ↗
33. Chen C (2014) The citespace manual. Coll Comput Informat 1:1–84
34. Della Rocca J, Liu D, Lin W (2011) Nanoscale metal-organic frameworks for biomedical imaging and drug delivery. Acc Chem Res 44:957–968. https://doi.org/10.1021/ar200028a10.1021/ar200028a ↗
35. He C, Lu K, Liu D, Lin W (2014) Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells. J Am Chem Soc 136:5181–5184. https://doi.org/10.1021/ja409886210.1021/ja4098862 ↗
36. Horcajada P, Chalati T, Serre C, Gillet B, Sébrié C, Baâti T, Eubank JF, Heurtaux D, Clayette P, Kreuz C et al (2010) Porous metal-organic-framework nanoscale carriers as a potential platform for drug deliveryand imaging. Nat Mater 9:172–178. https://doi.org/10.1038/nmat260810.1038/nmat2608 ↗
37. Li SY, Cheng H, Xie BR, Qiu WX, Zeng JY, Li CX, Wan SS, Zhang L, Liu WL, Zhang XZ (2017) Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy. ACS Nano 11:7006–7018. https://doi.org/10.1021/acsnano.7b0253310.1021/acsnano.7b02533 ↗
38. Lu K, He C, Lin W (2014) Nanoscale metal-organic framework for highly effective photodynamic therapy of resistant head and neck cancer. J Am Chem Soc 136:16712–16715. https://doi.org/10.1021/ja508679h10.1021/ja508679h ↗
39. Park J, Jiang Q, Feng D, Mao L, Zhou HC (2016) Size-controlled synthesis of porphyrinic metal-organic framework and functionalization for targeted photodynamic therapy. J Am Chem Soc 138:3518–3525. https://doi.org/10.1021/jacs.6b0000710.1021/jacs.6b00007 ↗
40. Rieter WJ, Pott KM, Taylor-Pashow KML, Lin W (2008) Nanoscale coordination polymers for platinum-based anticancer drug delivery. J Am Chem Soc 130:11584–11585. https://doi.org/10.1021/ja803383k10.1021/ja803383k ↗
41. Zhang Y, Wang F, Liu C, Wang Z, Kang L, Huang Y, Dong K, Ren J, Qu X (2018) Nanozyme decorated metal-organic frameworks for enhanced photodynamic therapy. ACS Nano 12:651–661. https://doi.org/10.1021/acsnano.7b0774610.1021/acsnano.7b07746 ↗
42. Zheng H, Zhang Y, Liu L, Wan W, Guo P, Nyström AM, Zou X (2016) One-pot synthesis of metal-organic frameworks with encapsulated target molecules and their applications for controlled drug delivery. J Am Chem Soc 138:962–968. https://doi.org/10.1021/jacs.5b1172010.1021/jacs.5b11720 ↗
43. Zhuang J, Kuo CH, Chou LY, Liu DY, Weerapana E, Tsung CK (2014) Optimized metal-organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation. ACS Nano 8:2812–2819. https://doi.org/10.1021/nn406590q10.1021/nn406590q ↗
44. Wang Y, Zhang X, Zhang Y, Shi F, Du S, Zhang Z, Zhao C, Luo S, Wang P, Wu D et al (2025) Sprayed hyaluronic acid based multidrug composite hydrogel for postoperative colorectal cancer ultra-efficient long-lasting multi-stage immuno-chemo synergistic therapy. Mater Horiz 12:4317–4335. https://doi.org/10.1039/d5mh00108k10.1039/d5mh00108k ↗
45. Liu C, Guo L, Cheng Y, Gao J, Pan H, Zhu J, Li D, Jiao L, Fu C (2025) A mitochondria-targeted nanozyme platform for multi-pathway tumor therapy via ferroptosis and cuproptosis regulation. Adv Sci. https://doi.org/10.1002/advs.20241761610.1002/advs.202417616 ↗
46. Zhang S, Guo L, Tang Y, Wang Y, Liu H, Liu C, Yan X, Duan C, Dai H, Han B et al (2025) Self-reinforced nanoreactor for apoptosis/ferroptosis synergistic therapy of head and neck squamous cell carcinoma. Chem Eng J. https://doi.org/10.1016/j.cej.2025.16694110.1016/j.cej.2025.166941 ↗
47. ElZayat EM, Hassan NM, Mahmoud R, Ibrahim E, Hassan N (2025) MOF enhances the sensitivity and selectivity of sorafenib as an anticancer drug against hepatocellular carcinoma and colorectal cancer in vitro. Sci Rep. https://doi.org/10.1038/s41598-025-16803-x10.1038/s41598-025-16803-x ↗
48. Zeggai Fz, Ait-Touchente Z, Bachari K, Elaissari A (2025) Investigation of metal-organic frameworks (MOFs): synthesis, properties, and applications - an in-depth review. Chem Phys Impact 10:100864. https://doi.org/10.1016/j.chphi.2025.10086410.1016/j.chphi.2025.100864 ↗
49. Shukla S, Bagchi D, Divya, Khushi, Manohara Reddy YV, Park JP (2025) Multifunctional metal-organic frameworks in breast cancer therapy: advanced nanovehicles for effective treatment. Eur J Med Chem 289:117424. https://doi.org/10.1016/j.ejmech.2025.11742410.1016/j.ejmech.2025.117424 ↗
50. Desai N, Veras L, Gosain A (2018) Using Bradford’s law of scattering to identify the core journals of pediatric surgery. J Surg Res 229:90–95. https://doi.org/10.1016/j.jss.2018.03.06210.1016/j.jss.2018.03.062 ↗
51. Mavidis A, Folinas D, Skiadas D, Xanthopoulos A (2024) Emerging technologies revolutionising public procurement: insights from comprehensive bibliometric analysis. Adm Sci 14:29. https://doi.org/10.3390/admsci1402002310.3390/admsci14020023 ↗
52. Martinho VJPD (2022) Bibliographic coupling links: alternative approaches to carrying out systematic reviews about renewable and sustainable energy. Environments 9:2810.3390/environments9020028 ↗
53. Sun H, Qiu S, Luo K, Chen R, Liu H, Gao F (2025) Design of a porous and stable sodium alginate–silica composite for dual fluorescent detection of Fe3+ and 5-Fu in colorectal cancer treatment. Luminescence. https://doi.org/10.1002/bio.7031510.1002/bio.70315 ↗
54. Kidanemariam A, Cho S (2025) Metal–organic-framework-based optical biosensors: recent advances in pathogen detection and environmental monitoring. Sensors 25:508110.3390/s25165081 ↗
55. Guo JC, Feng QH, Yang S, Du J, Zhou X, Zhou SH, Zhang L, Ren X, Xie MJ (2025) Multifunctional drug delivery nanoparticles based on fe-containing metal–organic framework for fluorescence image-guided combined chemical/chemodynamic/photodynamic colorectal cancer treatment. ACS Appl Bio Mater 8:8160–8171. https://doi.org/10.1021/acsabm.5c0110210.1021/acsabm.5c01102 ↗
56. Xie Y, Xu Y, Liu Y, Mei Z, Tian J (2026) Metal-organic framework-based radiosensitizer for cancer therapy. Coord Chem Rev 546:217103. https://doi.org/10.1016/j.ccr.2025.21710310.1016/j.ccr.2025.217103 ↗
57. Zou Y, Zhang Q, Chen J, Wang W, Zheng X (2025) Metal-organic frameworks-loaded indocyanine green for enhanced phototherapy: a comprehensive review. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2025.160147610.3389/fbioe.2025.1601476 ↗
58. Koshy M, Spiotto M, Feldman LE, Luke JJ, Fleming GF, Olson D, Moroney JW, Nanda R, Rosenberg A, Pearson AT (2023) A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors10.1200/JCO.2023.41.16_suppl.2527 ↗
59. Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, Thamaraikani T, Vasanthan M, Viktor P, Lakshmaiya N et al (2023) Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer 22:169. https://doi.org/10.1186/s12943-023-01865-010.1186/s12943-023-01865-0 ↗
60. El-Shabasy RM, Zayed A, Farag MA, Shoueir KR (2026) Green synthesis of relevant and sustainable bio-applications of few-layer graphene: a multi-faceted review and future perspectives. Mater Today Sustain 33:101259. https://doi.org/10.1016/j.mtsust.2025.10125910.1016/j.mtsust.2025.101259 ↗
61. Vyas H, Bhardwaj M, Das A, Agarwal J, Tiwari AK (2026) Chapter 11 - Safety and regulatory considerations in nano-bio-medicine. In: Chaturvedi V, Singh J, Singh AK, Yadav DP (eds) Nano-Bio-Medicine for Gastrointestinal Diseases. Academic Press, pp 311–32810.1016/B978-0-443-34039-0.00002-0 ↗
62. Liu Y, Zhang Y, Li H, Hu TY (2025) Recent advances in the bench-to-bedside translation of cancer nanomedicines. Acta Pharm Sin B 15:97–122. https://doi.org/10.1016/j.apsb.2024.12.00710.1016/j.apsb.2024.12.007 ↗
63. Cobo MJ, López-Herrera AG, Herrera-Viedma E, Herrera F (2011) Science mapping software tools: review, analysis, and cooperative study among tools. J Am Soc Inf Sci Technol 62:1382–1402. https://doi.org/10.1002/asi.2152510.1002/asi.21525 ↗
64. Rastin F, Javid H, Oryani MA, Rezagholinejad N, Afshari A-R, Karimi-Shahri M (2024) Immunotherapy for colorectal cancer: rational strategies and novel therapeutic progress. Int Immunopharmacol 126:111055. https://doi.org/10.1016/j.intimp.2023.11105510.1016/j.intimp.2023.111055 ↗
65. Koshy M, Spiotto M, Feldman LE, Luke JJ, Fleming GF, Olson D, Moroney JW, Nanda R, Rosenberg A, Pearson AT et al (2023) A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors. J Clin Oncol 41:2527–2527. https://doi.org/10.1200/JCO.2023.41.16_suppl.252710.1200/JCO.2023.41.16_suppl.2527 ↗
66. Lu K, He C, Guo N, Chan C, Ni K, Lan G, Tang H, Pelizzari C, Fu Y-X, Spiotto MT et al (2018) Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy. Nat Biomed Eng 2:600–610. https://doi.org/10.1038/s41551-018-0203-410.1038/s41551-018-0203-4 ↗
67. Luo T, Fan Y, Mao J, Jiang X, Albano L, Yuan E, Germanas T, Lin W (2023) Metal-organic layer delivers 5-aminolevulinic acid and porphyrin for dual-organelle-targeted photodynamic therapy. Angew Chem Int Ed Engl 62:e202301910. https://doi.org/10.1002/anie.20230191010.1002/anie.202301910 ↗
68. Luo T, Fan Y, Mao J, Yuan E, You E, Xu Z, Lin W (2022) Dimensional reduction enhances photodynamic therapy of metal-organic nanophotosensitizers. J Am Chem Soc 144:5241–5246. https://doi.org/10.1021/jacs.2c0038410.1021/jacs.2c00384 ↗
69. Luo T, Jiang X, Fan Y, Yuan E, Li J, Tillman L, Lin W (2024) STING agonist-conjugated metal-organic framework induces artificial leukocytoid structures and immune hotspots for systemic antitumor responses. Natl Sci Rev. https://doi.org/10.1093/nsr/nwae16710.1093/nsr/nwae167 ↗
70. Luo T, Jiang X, Li J, Nash GT, Yuan E, Albano L, Tillman L, Lin W (2024) Phosphate coordination to metal-organic layer secondary building units prolongs drug retention for synergistic chemoradiotherapy. Angew Chem Int Ed 63:e202319981. https://doi.org/10.1002/anie.20231998110.1002/anie.202319981 ↗
71. Luo T, Nash GT, Jiang X, Feng X, Mao J, Liu J, Juloori A, Pearson AT, Lin W (2022) A 2D nanoradiosensitizer enhances radiotherapy and delivers STING agonists to potentiate cancer immunotherapy. Adv Mater 34:2110588. https://doi.org/10.1002/adma.20211058810.1002/adma.202110588 ↗
72. Xu Z, Luo T, Lin W (2021) Nanoscale metal–organic layers for biomedical applications. Acc Mater Res 2:944–953. https://doi.org/10.1021/accountsmr.1c0016110.1021/accountsmr.1c00161 ↗
73. Xu Z, Luo T, Mao J, McCleary C, Yuan E, Lin W (2022) Monte Carlo simulation-guided design of a thorium-based metal–organic framework for efficient radiotherapy-radiodynamic therapy. Angew Chem Int Ed 61:e202208685. https://doi.org/10.1002/anie.20220868510.1002/anie.202208685 ↗
74. Chen H, Liu R, Fu J, Zhang X, Zhu X, Wei M, Liu F, Yin P, Li H, Zhang Y et al (2025) Surface engineering of copper peroxide nanodots and Au nanozyme on porphyrin-based metal-organic frameworks induces cascade reactions for colorectal cancer treatment. Chem Eng J. https://doi.org/10.1016/j.cej.2025.16476410.1016/j.cej.2025.164764 ↗
75. Fang X, Wang T, Zhang Y, Song J (2025) Dual-functional silicon-based nanofluorescent platform for iron detection and capecitabine delivery in colorectal cancer treatment. J Fluoresc. https://doi.org/10.1007/s10895-025-04252-810.1007/s10895-025-04252-8 ↗
76. Lu YH, Leng F, Chen SY, Wang CY, Gou CL, Yu TT, Li LG, Li HT, Yan M, Zhang Q et al (2025) Using metal–organic framework nanoparticles for targeted codelivery of bortezomib and iron ions to mitochondrial TOM20 to induce ferroptosis for colorectal cancer treatment. Mol Pharm 22:4865–4878. https://doi.org/10.1021/acs.molpharmaceut.5c0048910.1021/acs.molpharmaceut.5c00489 ↗
77. Jiahui K, Yongqiang Z, Yuchang Y, Ziheng W, Xiaohong J, Shuting L, Hongyue C, Xiaoxv D, Changhai Q, Mengru C et al (2025) Biomimetic MOFs nanoparticles co-delivering oridonin and siRNA for synergistic therapy in melanoma via ferroptosis pathway. J Sci: Adv Mater Devices. https://doi.org/10.1016/j.jsamd.2025.10095710.1016/j.jsamd.2025.100957 ↗
78. Shi W, Li C, Wang N, Lu H, Miao G, Cai M, Yang J, Zhang Y, Qu Y, Tang Y et al (2025) Fe-doped carbon dots control the biodegradation behaviors of Zr-Based metal–organic framework for tumor-specific chemotherapy and ferroptosis enhanced sono-chemodynamic therapy. Small. https://doi.org/10.1002/smll.20250202810.1002/smll.202502028 ↗
79. Yan Z, Bai Y, Zhang S, Kong L, Wang Y, Sun H, Li Y, Qiu L, Zhang R, Jiang P et al (2025) Quasi Fe MIL-53 nanozyme inducing ferroptosis and immunogenic cell death for cancer immunotherapy. Nat Commun. https://doi.org/10.1038/s41467-025-57542-x10.1038/s41467-025-57542-x ↗